$CLBT Balance Sheet | Understand Stock

$CLBT

$11.93 -$0.30 (2.45%) Close

$CLBT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets
Restricted cash
Cash and cash equivalents
Short-term deposits
Marketable securities
Trade receivables (net of allowance for credit losses of $506 and $594 as of December 31, 2025 and December 31, 2024, respectively)
Prepaid expenses and other current assets
Contract acquisition costs
Inventories
Total current assets

Non-current assets
Other non-current assets
Marketable securities
Deferred tax assets, net
Property and equipment, net
Operating Lease, Right-of-Use Asset
Intangible assets, net
Goodwill
Total non-current assets
Total assets
Liabilities and Equity
Current liabilities
Trade payables
Deferred revenues
Other accounts payable and accrued expenses
Operating lease liabilities
Total current liabilities
Long-term liabilities
Liability for employees’ severance benefits
Other long-term liabilities
Operating lease liabilities
Deferred revenues
Restricted Sponsor Shares liability
Price Adjustment Shares liability
Derivative warrant liabilities
Derivative warrant liability
Total long-term liabilities

Total liabilities
Redeemable convertible preferred shares, NIS 0.00001 par value; 39,779,261 shares authorized, issued and outstanding as of December 31, 2020. Aggregate liquidation preference of $134,411, as of December 31, 2020**
Equity
Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized and 187,680,294 and 124,671,507 shares issued and outstanding as of December 31, 2021 and 2020, respectively**
Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized, 248,622,818 and 234,566,473 shares issued and 248,581,042 and 234,524,697 shares outstanding as of December 31, 2025 and 2024, respectively
Additional paid-in capital
Common stock par value per share (in NIS per share)
Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated deficit
Total Shareholders’ equity

Total liabilities and shareholders’ equity

Comments